New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
Uttar Pradesh Govt Expands Startup Push With 7 Centres Of Excellence To Boost Innovation And Entrepreneurship
Allahabad HC Refuses Relief To Marion Biotech, Allows Trial In Child Deaths Linked To Cough Syrup Case
Uttar Pradesh Police Issues Revised Transfer Policy With Compassionate Provisions For Husband-Wife And Medical Cases
Maharashtra Civic Elections 2026 Results: From ‘Temporary Rebel’ To Power Broker, Dy CM Eknath Shinde Cements Political Relevance
